期刊文献+

青蒿素类药物与其他药物配伍治疗疟疾的研究进展 被引量:11

Progress of research on artemisinin in combination with other anti-malarial drugs
原文传递
导出
摘要 近年来抗疟药耐药现象的出现严重影响了疟疾的防治,新药的研发和疟疾疫苗的研究离临床应用还存在一定距离,联合用药是疟疾治疗的有效途径,已成为当今疟疾防治研究的热点。本文综述了青蒿素类药物与其他药物联合治疗疟疾的研究进展。 Antimalarial drug resistance in recent years has seriously affected the prevention and treatment of malaria.There is still a definite gap between the development of new drugs and malaria vaccine research and their clinical use.Drug combination therapy is an effective means of malaria control that has become a focus of research.This review summarizes the current development of artemisinin-based drug combinations for the treatment of malaria.
出处 《中国病原生物学杂志》 CSCD 2009年第3期232-235,239,共5页 Journal of Pathogen Biology
基金 国家自然科学基金资助项目(No.30560022)
关键词 青蒿素 联合治疗 疟疾 抗疟疾药物 综述 Artemisinin drug combination malaria anti-malarial drugs review
  • 相关文献

参考文献38

  • 1Susceptibility of Plasmodium falciparum to antimalarial drugs: Report on global monitory: 1996 - 2004 [R]. Geneva, World Health Organization (WHO/HTM/MAL/2005,1103).
  • 2Why the world needs another malaria initiative[C]. Lancet,2004, 364(9432) :389-390.
  • 3Chen PQ, Guo XB, Li GQ, et al. Effect of dihydroartemisinin on the infectivity of P. falciparum gameto cytes(PFG) and a randomized comparative study with quinine. ⅪⅤth International Congress for Tropical Medicine and Malaria. Abstracts[C]. Nagasaki Japan,1996. 211.
  • 4The use of antimalarial drugs: Report of WHO technical consultation[R]. Geneva, World Health Organization, 2001 (WHO/CDS/ RBM/2001,33).
  • 5Antimalarial drugs combination therapy.. Report of WHO technical consultation, 4 - 5 April 2001 [R]. Geneva, World Health Organization (WHO/CDS/RBM/2001,35).
  • 6Guidelines for the treatment of malaria[R]. Geneva, World Health Organization (WHO/HTM/MAL/2006,1108).
  • 7White NJ. Antimalaria drug resistance and combination chemotherapy[J]. Philos Trans R Soc Lond Bilo Sci, 1999,354: 739-749.
  • 8Davis TM,Engtand M,Dunlop AM,et al. Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers[J]. Antimicrob Agents Chemother, 2007,51 (3) : 1099- 1101.
  • 9Thuy le TD, Hung le N, Hung NC, et al. Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria [J]. Southeast Asian J Trop Med Public Heahh,2007,38(2):205-212.
  • 10Diem Thuy le T, Na-Bangchang K, Hung le N, et al. Clinical efficacy of high dose monotherapy of oral dihydroartemisinin in uncomplicated faleiparum malaria in viet nam[J]. Jpn J Infect Dis, 2007,60(4) : 161 - 166.

二级参考文献17

  • 1郭兴伯,符林春.双氢青蒿素与磷酸喹哌治疗恶性疟的随机比较[J].中华医学杂志,1993,73(10):602-604. 被引量:6
  • 2李兴亮,杨沧江.两种疗程双氢青蒿素片对恶性疟和间日症疗效的观察[J].实用寄生虫病杂志,1995,3(2):66-68. 被引量:7
  • 3刘德全,刘瑞君,张春勇,蔡贤铮,唐铣,杨恒林,杨品芳,董莹.我国恶性疟原虫对抗疟药敏感性的现状[J].中国寄生虫学与寄生虫病杂志,1996,14(1):37-41. 被引量:49
  • 4咯萘啶研究协作组.磷酸咯萘啶治疗510例疟疾现症病人的观察[J].中华内科杂志,1985,24(11):646-646.
  • 5康万民 杨仁政 等.咯萘啶治疗间日疟的疗效观察[J].寄生虫与寄生虫病杂志,1984,2(4):263-263.
  • 6黄在松 邵葆若 等.磷酸咯萘啶、磺胺多辛、乙胺嘧啶伍用治疗恶性疟的疗效[J].中国寄生虫学与寄生虫病杂志,1988,6:285-288.
  • 7车立刚.云南恶性疟抗氯喹株地理分布调查报告[J].中华流行病学杂志,1986,7(2):88-91.
  • 8Ministério da Saúde. Dados estatísticos de Saúde em 2002 anual[C].República da Guiné Bissau,2003.3-4.
  • 9薛纯良.疟疾[A].见:龚兰生主编.内科手册[M]:第4版[C].上海:上海科技出版社,2000.248-250.
  • 10钟惠澜 刘尔翔 朱师晦.疟疾[A].见:钟惠澜主编.热带医学[M]:第1版[C].北京:人民卫生出版社,2001.649-677.

共引文献32

同被引文献195

引证文献11

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部